Clinical Trials Directory

Trials / Completed

CompletedNCT02100345

Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound

Status
Completed
Phase
Study type
Observational
Enrollment
98 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Background: Endometriosis is a disease affecting 8-15 % of fertile women and is a cause of abdominal pain and suffering during women's menstrual periods. A subgroup of patients with DIE has an infiltration into the rectosigmoid bowel wall (4-37%). Knowledge of the growth pattern of rectosigmoid lesions related to subjective symptoms is mandatory in order to assess the need for follow-up with transvaginal ultrasound during medical treatment. Hypotheses: Symptoms will follow growth of rectosigmoid endometriosis. Material and methods: Two different cohorts of women, based on time of diagnosis of rectosigmoid endometriosis and treatment with hormonal intrauterine device or continuous oral contraceptives will receive a questionnaire and a transvaginal ultrasound scan (measuring size and volume) at inclusion, (6) and 12 months later. Perspectives: Patients treated conservatively may be followed by questionnaires, thereby reducing the need for time consuming clinical controls.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2014-03-31
Last updated
2017-05-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02100345. Inclusion in this directory is not an endorsement.